Clinical Trial Update: Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome [Phase 3]

View source ↗

Summary

Phase 3 compassionate-use trial evaluating epithelial-on corneal collagen crosslinking with UVA exposure for eyes with ectatic corneal diseases in subjects with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Forme Fruste Keratoconus
• Keratoconus
• Pellucid Marginal Degeneration

Drugs mentioned

• Epi-ON Corneal Collagen Crosslinking (epithelial-on corneal collagen crosslinking with UVA exposure)

Snippet

Sponsor: Woolfson Eye Institute | Conditions: Down Syndrome (DS), Keratoconus | Phase 3 | Status: RECRUITING